ASCO25

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

ASCO25
Jun 3, 2025, 08:09 | Blog
Galip Can Uyar: ASCO25 - Bridging Gaps in Exercise Access for Oncology Care in Latin America
Galip Can Uyar, Medical Oncologist at Etlik City Hospital, shared an article on X: "When…
Jun 3, 2025, 08:06 | Blog
Nazik Hammad Expresses Gratitude to Mentees After ASCO Award Recognition
Nazik Hammad, Medical Oncologist and Professor at St. Michael’s Hospital, posted on X: "Grateful to…
Jun 3, 2025, 07:55 | Blog
Jasmine Kamboj: Fantastic Time at Dr Robin Zon’s Presidential Reception
Jasmine Kamboj, Medical Oncologist and Hematologist at Mayo Clinic, posted on X: "Fantastic time at…
Jun 3, 2025, 07:47 | Blog
Brian Rini: ASCO25 Final Results of IO-based Combinations in mRCC are in
Brian Rini, Chief of Clinical Trials at Vanderbilt University, posted on X: "ASCO25 Final results…
Jun 3, 2025, 07:37 | Blog
Sergio Cifuentes Reflects on Memorable Moments at ASCO 2025
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, posted on X: "I wait for…
Jun 3, 2025, 07:30 | Blog
Aakash Desai: NSCLC Treatment Updates at ASCO 2025 Lung Cancer Session
Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at…
Jun 3, 2025, 04:59 | Blog
Abner Antonio Murray: Helena Yu Presented Promising Data for Zipalertinib in Previously Treated EGFR ex20ins NSCLC at ASCO25
Abner Antonio Murray, Hematology/Oncology Fellow at UNC School of Medicine, shared a post on X:…
Jun 3, 2025, 04:40 | Blog
Heber Reyes: ASCO25 Highlights - Practice Changes and Considerations for Oncologists
Heber Reyes, Medical Oncologist at ISSSTE, shared a post on X: "So, after Plenary Session…
Jun 3, 2025, 04:32 | Blog
Giannis Mountzios: Tony Mok Presented Herthena - Lung 03 With Patritumab DXd vs PBC in EGFR Mutation NSCLC at ASCO25
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Jun 2, 2025, 21:29 | Blog
Elvina Almuradova: The SERENA-6 Trial Introduces a New Standard in ESR1-mutant ER+/HER2- Advanced Breast Cancer
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
Jun 2, 2025, 18:21 | Blog
Richard Lee: SIO Team Presented Real-World Implementation of ASCO-SIO Guidelines at ASCO25
Richard Lee, Clinical Professor and Director at Cherng Family Center for Integrative Oncology, shared a…
Jun 2, 2025, 18:13 | Blog
Chris Poulios: ASCO25 Sessions Include Patients' Perspective Along With Clinical and Laboratory-Focused Talks
Chris Poulios, Steering Committee Member of Young Cancer Professionals at the European Cancer Organisation, shared…
Jun 2, 2025, 18:00 | Blog
Shabnam Gujadhur: Day 2 at ASCO - Innovation, Insights, and Inspiration
Shabnam Gujadhur, Medical Doctor at Gold Coast Hospital and Health Service, Lecturer at Griffith University, shared a…
Jun 2, 2025, 17:43 | Blog
Gilberto Lopes Highlights Key Insights from Lung Oral Session at ASCO25
Gilberto Lopes, Medical Director for International Programs and Associate Director at the Sylvester Comprehensive Cancer…
Jun 2, 2025, 17:33 | Blog
Shivani Modi: Honored to Present Our Poster on Quantifying Financial Toxicity in Oncology at ASCO25
Shivani Modi, Resident Physician at Jefferson Health, shared a post on X: "Honored to present…
Jun 2, 2025, 17:30 | Blog
Elvina Almuradova Shares ATOMIC Trial Results Showing Reduced Recurrence in dMMR Colon Cancer
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
Jun 2, 2025, 17:18 | Blog
Narjust Florez: Couldn’t Ask for a Better Partner as New IASLC Board Member
Narjust Florez, Co-Director of the Young Lung Cancer Program at Dana-Farber Cancer Institute, shared a…
Jun 2, 2025, 17:06 | Blog
Yüksel Ürün Highlights ML-integrated Biomarker Insights from CheckMate 9ER
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on…
Jun 2, 2025, 16:15 | Science
Pashtoon Kasi Shares Results from LODESTAR Trial on Rucaparib in HRR-Mutated Solid Tumors
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared…
Jun 2, 2025, 15:20 | Insight
Agenus Presented New Translational Data at the ASCO 2025
Agenus, a leader in immuno-oncology, presented new translational data at the 2025 American Society of…
Jun 2, 2025, 13:25 | Blog
Roupen Odabashian: Artificial Intelligence as a Clinical Decision Support tool for Lung Cancer Treatment Recommendations
Roupen Odabashian, Hematology/Oncology Fellow at the Karmanos Cancer Institute, shared a post on LinkedIn: "Publications alert…
Jun 2, 2025, 13:13 | Blog
Aakash Desai: ASCO25 set to showcase some innovative SCLC LCSM Research
Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at the…
Jun 2, 2025, 12:48 | Blog
Pam Mangat-Dhaliwal: One of the best events during ASCO25
Pam Mangat-Dhaliwal, Division Director, Clinical Research and Analytics at American Society of Clinical Oncology, shared…
Jun 2, 2025, 11:36 | Blog
Supriya Peshin: Science Can Be Powerful and Playful
Supriya Peshin, Visiting Resident in Hematology and Oncology at MD Anderson Cancer Center, shared on…
Jun 2, 2025, 11:12 | Blog
Mehndi Dandwani Highlights the Value of Mentorship in Oncology
Mehndi Dandwani, Haematology-oncology Fellow at the University of Iowa Health Care, shared on X: "Nothing…
Jun 2, 2025, 10:36 | Blog
Jasmine Kamboj: Check out Shivani Modi's Poster Presented at ASCO 2025
Jasmine Kamboj, Medical Oncologist and Hematologist at Mayo Clinic, shared on X: "If you have…
Jun 2, 2025, 09:10 | Blog
Mario Balsa: POLCA-GB at ASCO25
Mario Balsa, Medical Oncology resident at ICO, posted on X: "POLCA-GB at ASCO25 Preop chemoradiation…
Jun 2, 2025, 09:07 | Science
PSOGI Highlights CAIRO-6 Trial Outcomes on HIPEC and Chemotherapy in Colorectal Peritoneal Metastases
Peritoneal Surface Oncology Group International (PSOGI) shared a post on LinkedIn: "Congratulations to the investigators…
Jun 2, 2025, 09:06 | Blog
Abner Antonio Murray: KRYSTAL-7 Trial at ASCO25
Abner Antonio Murray, Hematology/Oncology Fellow at UNC School of Medicine, posted on X: "KRYSTAL-7 |…
Jun 2, 2025, 08:50 | Blog
Sergio Cifuentes Calls for Greater LATAM Inclusion in Global Oncology Agenda
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, posted on LinkedIn: "Advocating for LATAM.…
Jun 2, 2025, 08:33 | Blog
Matthew Kurian: Day 2 at ASCO25 - and ASCENT-04 Stole the Show!
Matthew Kurian, Assistant Professor of Medicine at the University of Kentucky College of Medicine, posted…
Jun 2, 2025, 08:24 | Blog
Richard Simcock: ASCO Day 2 - Podcasts, Trust and "Why not?"
Richard Simcock, Chief Medical Officer at Macmillan Cancer Support, recently posted on LinkedIn: "A sunny…
Jun 2, 2025, 08:11 | Blog
Daniel Sumarriva: An Unforgettable Night at ASCO25 with SAGA Diagnostics
Daniel Sumarriva, Executive Medical Director at SAGA Diagnostics, posted on LinkedIn: "An unforgettable night at…
Jun 2, 2025, 07:56 | Blog
Teresa Amaral Presents CP-GEP Data in Head and Neck Melanoma at ASCO 2025
Teresa Amaral, Consultant Medical Oncologist and the Head of Skin Cancer Clinical Trials Center at…
Jun 2, 2025, 07:48 | Blog
Sarah Premji: ASCO25 Day 2 - Practice-Changing Data and Featured in ASCO Daily News
Sarah Premji, Clinical Oncology Fellow at Mayo Clinic, posted on X: "ASCO25 day 2 was…
Jun 2, 2025, 07:46 | Blog
Ruben Mesa: Amazing Evening at our Advocate Health Cancer ASCO25 Reception
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health…
Jun 2, 2025, 06:59 | Blog
Armando Orlandi: Day 3 of ASCO25 - Key Breast Cancer Updates
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, posted on LinkedIn:…
Jun 2, 2025, 05:15 | Blog
Inizio Experts Sat Down With OncoDaily For Exclusive Interviews Series at ASCO25
Inizio shared a post on LinkedIn: "Live from the floor at ASCO25, our experts just…
Jun 2, 2025, 03:36 | Blog
New data highlighting botensilimab’s immune activation in MSS colorectal cancer - Agenus
Agenus shared a post on LinkedIn: "At ASCO25, we shared new data highlighting botensilimab’s immune…
Jun 1, 2025, 18:59 | Oncolibrary
SERENA-6 Trial at ASCO 2025: Camizestrant Plus CDK4/6i Improves Outcomes in HR+/HER2– Advanced Breast Cancer with ctDNA-Detected ESR1 Mutations
At ASCO 2025, results presented by Turner Nicholas from the global Phase 3 SERENA-6 trial…
Jun 1, 2025, 18:09 | Blog
Michael Jefford: Grateful for ASCO25’s Valuable Survivorship Session
Michael Jefford, Professorial Fellow at the University of Melbourne and also the Director at the…
Jun 1, 2025, 16:55 | Blog
Oriol Mirallas: Early Data on SYNC-T Therapy for mCRPC Presented at ASCO 2025
Oriol Mirallas, Medical Oncology Specialist at Vall d’Hebron Institute of Oncology, shared a post on X: "Drug…
Jun 1, 2025, 16:52 | Blog
Armando Orlandi: Racial Disparities in HER2+ Breast Cancer Outcomes at ASCO 2025
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, posted on X:…
Jun 1, 2025, 16:39 | Oncolibrary
MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment
At ASCO 2025 Plennary Session,  MATTERHORN trial results were presented by Dr. Yelena Janjigian, from…
Jun 1, 2025, 16:37 | Opinion
Massimo Di Maio: Overall Survival Analysis Should NOT be Adjusted for Subsequent Treatments
Massimo Di Maio, Associate Professor of Medical Oncology at Department of Oncology, University of Turin,…
Jun 1, 2025, 16:37 | Blog
Paolo Tarantino Shares DB06 Biomarker Analysis Insights from ASCO 2025
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post by Luiza Pamela Beato,…
Jun 1, 2025, 16:26 | Blog
Runcie C.W. Chidebe: Project PINK BLUE is Exhibiting at the ASCO25 Annual Meeting
Runcie C.W. Chidebe, Executive Director of Project PINK BLUE, posted on X: "Dear ASCO Fam,…
Jun 1, 2025, 16:26 | Blog
Oyepeju Abioye-Akintola: Thank you to the ecancer team for the wonderful interview at ASCO 2025
Oyepeju Abioye-Akintola, Internal Medicine Resident Physician at Allegheny Health Network, Administrative Director at Excellence in…
Jun 1, 2025, 16:23 | Insight
Key Insights by Talha Badar from ASCO25
The American Society of Clinical Oncology (ASCO) 2025 annual meeting once again showcased groundbreaking research…
Jun 1, 2025, 16:15 | Blog
Tingting Zhang: 6 years Since Meeting Julie Gralow at 2019 ASCO Women in Oncology Mentoring Hour
Tingting Zhang, Patient Advocate, shared a post on X: "6 years since meeting Julie Gralow…
Jun 1, 2025, 16:11 | Blog
Neeraj Agarwal Highlights STELLAR-002 Results in ccRCC at ASCO 2025
Neeraj Agarwal, Postdoctoral fellow at City of Hope, posted on X: "Congrats Jad Chahoud on…
Jun 1, 2025, 16:03 | Blog
Jason Westin: It Was a Great Honor to be Inducted as a FASCO at ASCO 2025
Jason Westin, Professor, Director of Lymphoma Clinical Research and Section Chief of Aggressive Lymphoma at…
Jun 1, 2025, 16:02 | Blog
Sarah Premji Shares ASCENT-04 Trial Outcomes in First-Line TNBC Treatment at ASCO 2025
Sarah Premji, Clinical Oncology Fellow at Mayo Clinic, posted on X: "ASCENT-04 met TNBC evaluating…
Jun 1, 2025, 14:52 | Insight
Key Insights by Tom Powles from ASCO25
The ASCO Annual Meeting 2025 is now in full swing in Chicago! From May 30…
Jun 1, 2025, 13:02 | Oncolibrary
CheckMate 214 Trial Final 9-Year Results at ASCO 2025: Nivolumab Plus Ipilimumab Continues to Show Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Presented by Dr. Robert J. Motzer at ASCO 2025, the final 9-year follow-up results from…
Jun 1, 2025, 11:42 | Blog
Estela Rodriguez: Day 2 ASCO25 Agenda
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead Thoracic Site Disease Group of the Sylvester…
Jun 1, 2025, 11:40 | Blog
Zeynep Irem Ozay: High KIM-1/Teff Shows Longer DFS With Adjuvant Atezolizumab vs Placebo
Zeynep Irem Ozay, Postdoctoral Research Fellow at Huntsman Cancer Institute, shared a post on X: "Brilliant…
Jun 1, 2025, 11:35 | Blog
Mario Balsa: Breaking from ASCO 2025 - DESTINY-Gastric04 Trial
Mario Balsa, Medical Oncology resident at ICO, Shared a post on X: "Breaking from ASCO25 —…
Jun 1, 2025, 11:33 | Blog
Cristiane Bergerot: Genomic Insights from IMmotion010
Cristiane Bergerot, Director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital, shared a…
Jun 1, 2025, 11:25 | Blog
Michael Serzan: Kidney Clinical Science Symposium at ASCO25
Michael Serzan, Genitourinary Medical Oncologist at Dana Farber Cancer Institute, shared a post on X:…
Jun 1, 2025, 11:07 | Blog
Armando Orlandi: ASCO25 Breast Cancer Update, Early Data from May 30th Session
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post on…
Jun 1, 2025, 10:46 | Blog
Jasmine Kamboj: Two brilliant Advocacy and Policy sessions at ASCO25
Jasmine Kamboj, Medical Oncologist and Hematologist at Mayo Clinic, shared a post on LinkedIn: "Two brilliant…
Jun 1, 2025, 10:18 | Blog
Heidi Ko: ASCO Is Not Just a Conference - It’s a Powerful Reminder of Progress in Cancer Research
Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, shared a post on…
Jun 1, 2025, 10:11 | Blog
Abdul Rahman Jazieh: Honoring board members who finished their term and ASCO president, Robin Zon
Abdul Rahman Jazieh, Chief Executive Officer at Innovative Healthcare Institute, shared a post on LinkedIn: "American…
Jun 1, 2025, 10:03 | Blog
Matthew Kurian: Highlights from Day 1 at ASCO25’s Metastatic Breast Cancer Data that stood out
Matthew Kurian, Assistant Professor of Medicine at the University of Kentucky College of Medicine, shared a…
Jun 1, 2025, 09:48 | Blog
Aakash Desai: ASCO25 Set to Showcase Some Innovative SCLC Research
Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at…
Jun 1, 2025, 09:36 | Blog
Armando Orlandi: Historic PROTAC Milestone and Pivotal Phase 3 Results on ASCO25 Day 2
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post on…
Jun 1, 2025, 09:14 | Blog
Ruben Mesa Joins ASCO25 Panel on Community Health Workers in Cancer Care
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake…
Jun 1, 2025, 09:12 | Blog
Abdulla Alzibdeh: Happy to Meet Rebecca Snyder through the JCO Central Mentoring Meeting at ASCO 2025
Abdulla Alzibdeh, Resident Physician at King Hussein Cancer Foundation and Center, shared on LinkedIn: "I was…
Jun 1, 2025, 09:04 | Blog
Elvina Almuradova: ER Expression May Change Post-NAC - Should We Be Retesting?
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
Jun 1, 2025, 09:00 | Blog
Gertjan Rasschaert: TCR dynamics after first dose BOTBAL are predictive for response
Gertjan Rasschaert, Medical Doctor and Consultant specializing in Gastrointestinal Oncology and Gastroenterology at UZ Leuven, shared…
Jun 1, 2025, 08:28 | Insight
Matthew Kurian: Day 1 at ASCO 2025 – Bringing the Voice of the Community Oncologist to the Table
Matthew Kurian, Assistant professor of Medicine at the University of Kentucky College of Medicine, shared…
Jun 1, 2025, 08:04 | Insight
Armando Orlandi: ASCO25 Breast Cancer Update - Early Data from May 30th Session
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, posted on LinkedIn: "ASCO25…
Jun 1, 2025, 07:03 | Societies
15 Posts Not to Miss from the 2nd Day of ASCO 2025
The ASCO Annual Meeting 2025 is officially underway in Chicago! Running from May 30 to…
Jun 1, 2025, 07:03 | Blog
Celebrating Excellence in Oncology: Yvonne Awards 2025 at ASCO Annual Meeting
The Yvonne Awards 2025, presented by OncoDaily during the ASCO Annual Meeting in Chicago, brought…
Jun 1, 2025, 06:58 | Blog
Noha Soror Thanks ASCO 2025 Attendees for Poster Session Engagement
Noha Soror, Hematology-oncology Fellow at the University of Oklahoma, posted on X: "A heartfelt thank…
Jun 1, 2025, 06:42 | Blog
Charu Aggarwal: Fantastic Representation of Thoracic Oncology ASCO25 Posters
Charu Aggarwal, Leslye M. Heisler Professor of Lung Cancer Excellence at at the University of…
Jun 1, 2025, 06:27 | Blog
Alfonso Gómez de Liaño Highlights CREST Trial Insights in BCG-Unexposed Bladder Cancer at ASCO 2025
Alfonso Gómez de Liaño, Medical Oncologist at the Insular-Materno Infantil University Hospital Complex, posted on…
Jun 1, 2025, 06:15 | Blog
Gaia Griguolo: PROs from EMBER3 Trial Presented at ASCO25
Gaia Griguolo, Junior Faculty Fixed-term Researcher at University of Padua, posted on X: "PROs from…
Jun 1, 2025, 06:11 | Blog
Aakash Desai: It’s Only Saturday of ASCO25 and My Heart is Full
Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at…
Jun 1, 2025, 06:05 | Blog
Heidi Ko: What ASCO25 Means to Me as an Oncologist
Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, posted on LinkedIn: "What…
Jun 1, 2025, 05:59 | Opinion
Shabnam Gujadhur: Day 1 at ASCO 2025 Was All About the Human Side of Oncology
Shabnam Gujadhur, Medical Doctor at Gold Coast Hospital and Health Service, Lecturer at Griffith University …
Jun 1, 2025, 05:55 | Blog
Vishwanath Sathyanarayanan: Honored to have been Mentioned in Dr. Zon’s Presidential Address at ASCO25
Vishwanath Sathyanarayanan, Senior Consultant Medical Oncologist and Academic Advisor at Apollo Hospitals, shared a post…
Jun 1, 2025, 05:41 | Blog
Conquer Cancer Showcases Impact of Donor Support at ASCO 2025
Conquer Cancer posted on LinkedIn: "Sharing from ASCO25 in Chicago: Investing in the next generation…
Jun 1, 2025, 05:36 | Blog
Runcie C.W. Chidebe: Excited to be Attending ASCO25
Runcie C.W. Chidebe, Executive Director of Project PINK BLUE, posted on LinkedIn: "I am always…
Jun 1, 2025, 05:28 | Blog
Debra Patt: Excited to kick off the ASCO25 meeting with a dynamic session on AI in cancer care
Debra Patt, Chair of the AI Task Force and a Board Member for the American…
Jun 1, 2025, 05:25 | Blog
Jasmine Kamboj: Excellent Talk by Colleagues at ASCO25
Jasmine Kamboj, Medical Oncologist and Hematologist at the Mayo Clinic, posted on LinkedIn: "Excellent talk…
Jun 1, 2025, 05:22 | Blog
Chris Poulios: Yvonne Award 2025 Ceremony at ASCO 2025
Chris Poulios, Steering Committee Member of Young Cancer Professionals at the European Cancer Organisation, shared…
Jun 1, 2025, 05:18 | Blog
Heidi Klepin Has Received The ASCO25 B.J Kennedy Geriatric Oncology Award
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health…
Jun 1, 2025, 04:58 | Blog
Yan Leyfman: Excited to Present Research on GLP-1 Receptor Agonists at ASCO 2025
Yan Leyfman, Co-founder and Executive Director of MedNews Week, posted on LinkedIn: "Excited to present…
Jun 1, 2025, 04:21 | Science
Hiba Ali: Insightful Piece From The ASCO Educational Book on Building a Better Future With Artificial Intelligence
Hiba Ali, Oncology Medical Science Liaison for the Gulf Countries at AstraZeneca, shared a post…
Jun 1, 2025, 04:14 | Blog
Chinmay Jani: Excited to Kick Off ASCO25 with Insightful Sessions and Great Connections
Chinmay Jani, Clinical Fellow, Hematology and Oncology at University of Miami, shared on X: "ASCO25…
Jun 1, 2025, 00:32 | Insight
Arndt Vogel: 1st line encorafenib + cetuximab + mFOLFOX6 vs SOC in BRAF V600E-mCRC
Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and…
May 31, 2025, 23:25 | Blog
Heidi Ko: Amazing ASCO25 Opening Session on ctDNA in Colorectal Cancer Treatment
Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, posted on LinkedIn: "What…
May 31, 2025, 23:04 | Blog
Birute Brasiuniene: Great to Come Back to Annual Meeting of ASCO in Chicago
Birute Brasiuniene, Head of the Center of Medical Oncology, National Cancer Center of VULSK, shared…
May 31, 2025, 22:10 | Blog
Stacey Tinianov Shares Expectations for ASCO 2025 - From Knowledge to Action
Stacey Tinianov, Executive Director at Advocates for Collaborative Education, shared a post on LinkedIn: "Here…
May 31, 2025, 19:14 | Insight
Pre-surgical Combination Therapy Boosts Survival in Patients with Rare Thyroid Cancer
ASCO: Pre-surgical combination therapy boosts survival in patients with rare thyroid cancer Anaplastic thyroid cancer…
May 31, 2025, 18:59 | Blog
Working Together with ASCO to Make It Easier for Patients to Access Trusted Cancer Information - ACS CAN
American Cancer Society Cancer Action Network (ACS CAN) shared a post on LinkedIn: "We’re excited…
May 31, 2025, 18:56 | Blog
Amol Akhade: BREAKWATER Trial at ASCO 2025 - Raising the Bar in BRAF V600E–Mutant mCRC?
Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared a post on LinkedIn:…
May 31, 2025, 18:39 | Blog
Pembrolizumab Helps Head and Neck Cancer Patients Live Years Longer Cancer-Free - The Institute of Cancer Research
The Institute of Cancer Research shared a post on LinkedIn: "BREAKING: Researchers at the ICR…
All: 504 Posts: 201 - 300
Special Coverage